Find Funding Opportunities

The purpose of this notice is to add NINDS-specific research interests in PAS-22-196 "Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional)".

The overarching goal of this program is to enhance the retention of investigators facing critical life events who are transitioning from mentored career development awards to research independence and to minimize departures from biomedical research workforce. This supplement program is intended to ensure continuity of research among recipients of mentored career development (K) awards by providing supplemental research support to help sustain the investigators research during a period in which the PD/PI experiences critical life events which have the potential to impact research progress or potential productivity. Administrative supplements must support work within the scope of the original project.

The purpose of this notice is to add NINDS-specific research interests in PAS-22-197 "Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional)".

The overarching goal of this program is to enhance the retention of investigators facing critical life events who are transitioning to the first renewal of their first independent research project grant award or to a second new NIH research project grant award. Retention at the first renewal or continuous NIH research project grant support is crucial for sustaining both the ongoing research NIH has made an investment in and for retaining diverse talent in the biomedical research workforce. This program supports at-risk investigators as identified in the NIH Next Generation Researchers Initiative (see https://grants.nih.gov/ngri.htm).

The purpose of this Notice is to announce that the National Institute of Allergy and Infectious Diseases (NIAID), the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), the National Institute of Mental Health (NIMH), the National Institute of Neurological Disorders and Stroke (NINDS), and the National Center for Complementary and Integrative Health (NCCIH) encourage new applications to advance research activities relevant to the five strategic priorities identified in the recently released NIH Strategic Plan for Tickborne Disease Research:

The purpose of this notice is to inform applicants of a correction to the Eligibility Information for RFA-NS-22-011 "BRAIN Initiative: Research Resource Grants for Technology Integration and Dissemination (U24 Clinical Trial Not Allowed). For this Funding Opportunity Announcement (FOA), "Section III. Eligibility Information" has been corrected to allow intramural participation. This is consistent with the intramural participation language in "Section IV. Application and Submission Information, 7. Other Submission Requirements and Information".

The purpose of this time-sensitive Request for Information (RFI) is to seek input on the Draft ALS Strategic Plan from people living with amyotrophic lateral sclerosis (ALS), families, caregivers, people with genetic risk of ALS, advocates, scientists, clinicians, and the broader community.

On October 11, 2022, the National Institute on Drug Abuse and BRAIN Initiative published the Funding Opportunity Announcement, RFA-DA-23-030, BRAIN Initiative: Brain-Behavior Quantification and Synchronization Transformative and Integrative Models of Behavior at the Organismal Level (R34 Clinical Trial Not Allowed) to solicit applications supporting planning activities that will lay the groundwork for a scientific projects aiming to 1) develop and apply cutting-edge tools and methods for minimally invasive, multi-dimensional, high-resolution measurement of behavior at the level of the organism, with synchronous capture of data from the environment; and/or 2) develop computational methods that allow for integration of multidimensional behavioral and environmental data into a conceptual and/or computational model of behavior as a complex dynamic system. This Notice provides information regarding two upcoming Pre-Application Webinars for the above-referenced FOA. At these Webinars, Program and Review Officials from NIDA and other institutes participating in the BRAIN Initiative will provide a brief overview of this RFA and address questions from prospective applicants. Webinar Information Option 1 Date: Tuesday, November 22, 2022, Time: 11 am EST The webinar will be hosted through Zoom. Participants must register in advance for the webinar through the following link, after which a link to join the webinar will be e-mailed to the participant: NIH Zoom Webinar link: https://scgcorp.zoom.us/meeting/register/tZUkcOGrrj4jGtBm0XWaz_OYurAyDm… Option 2 Date: Monday, November 28, 2022, Time: 1 pm EST The webinar will be hosted through Zoom. Participants must register in advance for the webinar through the following link, after which a link to join the webinar will be e-mailed to the participant: NIH Zoom Webinar link: https://scgcorp.zoom.us/meeting/register/tZIqd-qvrTkrGNE22c1MQMmAdJ8Zf4…

The purpose of this notice is to correct the expiration date for PAR-22-181 "NCCIH, NEI, NIAAA, NIDA, NIMH, NINR, and NINDS Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)".

The purpose of this notice is to extend RFA-NS-22-021 "HEAL Initiative: Human Pain-associated Genes & Cells Data Coordination and Integration Center (U24 Clinical Trial Not Allowed)" by one council round.